O
GHDX

OppenheimerFunds’s Genomic Health, Inc. GHDX Stock Holding History

OppenheimerFunds’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$32.9M Buy
469,560
+108,337
+30% +$8.03M 0.04% 416
2018
Q4 		$23.3M Buy
+361,223
New +$25.3M 0.03% 464

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds's GHDX Position: Q1 2019 in Review

OppenheimerFunds increased its Genomic Health, Inc. (GHDX) stake by 30% in Q1 2019, buying an estimated $8.03M and bringing the position to 469,560 shares worth $32.9M. The position accounts for 0.04% of the portfolio, ranked #416.

OppenheimerFunds first reported a position in GHDX in Q4 2018 and has held it in 2 quarters since. 267 funds tracked by Wall St. Rank hold GHDX as of Q1 2019.

  • OppenheimerFunds held 469,560 shares of Genomic Health, Inc. worth $32.9M as of Q1 2019.
  • OppenheimerFunds bought 108,337 Genomic Health, Inc. shares in Q1 2019, an estimated $8.03M.
  • Genomic Health, Inc. made up 0.04% of OppenheimerFunds's portfolio in Q1 2019, its #416 holding.
  • OppenheimerFunds first reported a position in Genomic Health, Inc. in Q4 2018 and has held it in 2 quarters since.
  • 267 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.